Home
ST Pharm

ST Pharm Market Share Analysis for June 2026

- mRNA, 올리고 등 RNA 기반 치료제 플랫폼 사업 기술력 홍보 에스티팜(대표이사 사장 성무제)는 지난 19일부터 22일(현지시각)까지 미국 샌디에이고에서 열린 TIDES USA 2025 에 참가해 기술력 홍보에 나섰다고 26일 밝혔다. TIDES USA는 올리고 및 펩타이드 치료제 분야에서 세계 최대 규모를 자랑하는 국제 학회로, 글로벌 제약사와 바이오텍 기업들이 최신 연구 성과와 제조 기술, 시장 동향을 공유하는 권위 있는 행사로 꼽힌...

Health > Biotechnology and Pharmaceuticals

Domainstpharm.co.kr

Year Founded1983

Employees501 - 1000

Annual Revenue$100M - $200M

ST Pharm

ST Pharm (including company regionals)

stpharm.co.kr

See more website traffic and engagement information

ST Pharm Revenue up to June 2026 is 100M - 200M

revenue generated by ST Pharm top domains

ST Pharm top domains revenue over 3 years

Revenue for ST Pharm top domains

stpharm.co.kr100M - 200M

See more with Sales Intelligence

Total visits to ST Pharm's top domains

Understand ST Pharm market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

stpharm.co.kr18.6K

See more with Sales Intelligence

Avg. visit duration in ST Pharm's top domains

Analyze ST Pharm engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

stpharm.co.kr00:00:57

See more with Sales Intelligence

Avg. pageviews on ST Pharm's top domains

See how ST Pharm keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

stpharm.co.kr3.38

See more with Sales Intelligence

ST Pharm top competitors by domain

Top similar sites in June 2026, ranked by their affinity

midas-pharma.comCompany NameMidas Pharma GmbHEmployees201 - 500HQGermany, ingelheim am rheinAnnual revenue$50M - $75MTotal visits7.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by ST Pharm

These are the website technologies, by industry, used by ST Pharm top domains

Mobile (2)

Meta Viewport

Conversion & Analytics (1)

Matomo (Previously Piwik)

Other (1)

Google API

Widget (1)

Google Maps

News & Signals from ST Pharm

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsST Pharm Co. Ltd. expanded facilities to Ansan, South Korea, Eastern Asia, Asia on Sep 1st '25.In September 2025, South Korea's ST Pharm launched construction of a second oligonucleotide manufacturing facility in Ansan, Gyeonggi Province.

NewsST Pharm Co. Ltd. attended event IDWeek 2025 on Oct 1st '25.At IDWeek 2025, held on 19-22 October, Xue Meng from ST Pharm presented results from a proof of concept clinical trial for ST Pharm's investigational human immunodeficiency virus-1 (HIV-1) allosteric integrase inhibitor (ALLINI), pirmitegravir.

NewsST Pharm Co. Ltd. attended event TIDES USA 2025 on May 19th '25.ST Pharm (CEO Mooje Sung) announced on the 26th that it participated in TIDES USA 2025, held from May 19 to 22 (local time) in San Diego, to promote its technological capabilities in RNA-based therapeutics such as mRNA and oligonucleotides.